Contribution: Industrial Research Assistance Program – Contributions to Firms
RNA Diagnostics Inc.
$29,946.00
Assessment of RNA Disruption Using RNA Sequencing Technology
FY 2017-18 · 2017-08-01
Summary
This study will to investigate the feasibility of sequencing the major rRNAs in an RNA preparation using a nucleic acid sequencing technology in order to quantify the degree of rRNA fragmentation within the sample. RNA sequencing could then be used as a diagnostic tool to measure RNA disruption in samples taken from cancer patients during chemotherapy.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
822107868
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 94 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 94 jours.
Agreement End Date
2018-12-31
Agreement Number
891559
Agreement Start Date
2017-08-01
Agreement Title
Assessment of RNA Disruption Using RNA Sequencing Technology
Agreement Title (French)
Évaluation de la perturbation de l'ARN à l'aide de la technologie de séquençage de l'ARN
Agreement Type
Contribution
Agreement Value
$29,946.00
Amendment Date
2018-08-27
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This study will to investigate the feasibility of sequencing the major rRNAs in an RNA preparation using a nucleic acid sequencing technology in order to quantify the degree of rRNA fragmentation within the sample. RNA sequencing could then be used as a diagnostic tool to measure RNA disruption in samples taken from cancer patients during chemotherapy.
Description (French)
Cette étude examinera la faisabilité du séquençage des acides nucléiques ribosomiques (ARNr) principaux dans une préparation d'ARN en utilisant une technologie de séquençage des acides nucléiques afin de quantifier le degré de fragmentation de l'ARNr au sein de l'échantillon. Le séquençage de l'ARN pourrait alors être utilisé comme outil de diagnostic pour mesurer la perturbation de l'ARN dans des échantillons prélevés chez des patients cancéreux pendant la chimiothérapie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
University--Rosedale
Federal Riding (French)
University--Rosedale
Federal Riding Number
35110
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
822107868
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
RNA Diagnostics Inc.
Recipient Postal Code
M5G 1L7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q2-891559
